APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Supply Chain and Logistics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell and Gene Therapy Supply Chain and Logistics Market Outlook and Growth Opportunities 2026

Report ID 174087700411 April 2026Not stated

Choose your research edition.

Industry ResearchCell and Gene Therapy Supply Chain and Logistics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Supply Chain and Logistics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Supply Chain and Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Supply Chain and Logistics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Supply Chain and Logistics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Supply Chain and Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell and Gene Therapy Supply Chain and Logistics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell and Gene Therapy Supply Chain and Logistics market include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care and Haemonetics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell and Gene Therapy Supply Chain and Logistics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy Supply Chain and Logistics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy Supply Chain and Logistics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell and Gene Therapy Supply Chain and Logistics market.

Cell and Gene Therapy Supply Chain and Logistics Segment by Company

Be The Match BioTherapies

Biocair

Marken

World Courier

MAK-SYSTEM

Cryoport

Brooks Life Sciences

Hypertrust Patient Data Care

Haemonetics

MasterControl

TraceLink

TrakCel

Stafa Cellular Therapy

McKesson

BioLife Solutions

Patheon

SF Express

Cell and Gene Therapy Supply Chain and Logistics Segment by Type

Ordering and Scheduling Services

Sample Collection Services

Logistics Services

Post Treatment Follow-Up Services

Cell and Gene Therapy Supply Chain and Logistics Segment by Application

Biobank

Cell Therapy Lab

Hospital

Research Institute

Cell and Gene Therapy Supply Chain and Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell and Gene Therapy Supply Chain and Logistics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell and Gene Therapy Supply Chain and Logistics key companies, revenue, market share, and recent developments.

3. To split the Cell and Gene Therapy Supply Chain and Logistics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell and Gene Therapy Supply Chain and Logistics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell and Gene Therapy Supply Chain and Logistics significant trends, drivers, influence factors in global and regions.

6. To analyze Cell and Gene Therapy Supply Chain and Logistics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Supply Chain and Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Supply Chain and Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Supply Chain and Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Supply Chain and Logistics industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy Supply Chain and Logistics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell and Gene Therapy Supply Chain and Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell and Gene Therapy Supply Chain and Logistics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell and Gene Therapy Supply Chain and Logistics Industry Trends Table 2. Cell and Gene Therapy Supply Chain and Logistics Industry Drivers Table 3. Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges Table 4. Cell and Gene Therapy Supply Chain and Logistics Industry Restraints Table 5. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Company (2021-2026) Table 7. Global Cell and Gene Therapy Supply Chain and Logistics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell and Gene Therapy Supply Chain and Logistics Key Company Manufacturing Base & Headquarters Table 9. Global Cell and Gene Therapy Supply Chain and Logistics Company, Product Type & Application Table 10. Global Cell and Gene Therapy Supply Chain and Logistics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ordering and Scheduling Services Table 15. Significant Companies of Sample Collection Services Table 16. Significant Companies of Logistics Services Table 17. Significant Companies of Post Treatment Follow-Up Services Table 18. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type (2021-2026) Table 22. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biobank Table 24. Significant Companies of Cell Therapy Lab Table 25. Significant Companies of Hospital Table 26. Significant Companies of Research Institute Table 27. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application (2021-2026) Table 31. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application (2027-2032) Table 32. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Region (2021-2026) Table 35. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Region (2027-2032) Table 37. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Market Share by Country (2021-2026) Table 40. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Market Share by Country (2027-2032) Table 42. Be The Match BioTherapies Company Information Table 43. Be The Match BioTherapies Business Overview Table 44. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 46. Be The Match BioTherapies Recent Development Table 47. Biocair Company Information Table 48. Biocair Business Overview Table 49. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 51. Biocair Recent Development Table 52. Marken Company Information Table 53. Marken Business Overview Table 54. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 56. Marken Recent Development Table 57. World Courier Company Information Table 58. World Courier Business Overview Table 59. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 61. World Courier Recent Development Table 62. MAK-SYSTEM Company Information Table 63. MAK-SYSTEM Business Overview Table 64. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 66. MAK-SYSTEM Recent Development Table 67. Cryoport Company Information Table 68. Cryoport Business Overview Table 69. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 71. Cryoport Recent Development Table 72. Brooks Life Sciences Company Information Table 73. Brooks Life Sciences Business Overview Table 74. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 76. Brooks Life Sciences Recent Development Table 77. Hypertrust Patient Data Care Company Information Table 78. Hypertrust Patient Data Care Business Overview Table 79. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 81. Hypertrust Patient Data Care Recent Development Table 82. Haemonetics Company Information Table 83. Haemonetics Business Overview Table 84. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 86. Haemonetics Recent Development Table 87. MasterControl Company Information Table 88. MasterControl Business Overview Table 89. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 91. MasterControl Recent Development Table 92. TraceLink Company Information Table 93. TraceLink Business Overview Table 94. TraceLink Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 96. TraceLink Recent Development Table 97. TrakCel Company Information Table 98. TrakCel Business Overview Table 99. TrakCel Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 101. TrakCel Recent Development Table 102. Stafa Cellular Therapy Company Information Table 103. Stafa Cellular Therapy Business Overview Table 104. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 106. Stafa Cellular Therapy Recent Development Table 107. McKesson Company Information Table 108. McKesson Business Overview Table 109. McKesson Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 111. McKesson Recent Development Table 112. BioLife Solutions Company Information Table 113. BioLife Solutions Business Overview Table 114. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 116. BioLife Solutions Recent Development Table 117. Patheon Company Information Table 118. Patheon Business Overview Table 119. Patheon Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 121. Patheon Recent Development Table 122. SF Express Company Information Table 123. SF Express Business Overview Table 124. SF Express Cell and Gene Therapy Supply Chain and Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 126. SF Express Recent Development Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Supply Chain and Logistics Product Image Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell and Gene Therapy Supply Chain and Logistics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ordering and Scheduling Services Image Figure 8. Sample Collection Services Image Figure 9. Logistics Services Image Figure 10. Post Treatment Follow-Up Services Image Figure 11. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type (2021-2032) Figure 14. Biobank Image Figure 15. Cell Therapy Lab Image Figure 16. Hospital Image Figure 17. Research Institute Image Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application (2021-2032) Figure 21. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032) & (US$ Million) Figure 24. North America Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032) & (US$ Million) Figure 30. South America Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Ordering and Scheduling Services
  • Sample Collection Services
  • Logistics Services
  • Post Treatment Follow-Up Services
Applications
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
Companies covered
  • Be The Match BioTherapies
  • Biocair
  • Marken
  • World Courier
  • MAK-SYSTEM
  • Cryoport
  • Brooks Life Sciences
  • Hypertrust Patient Data Care
  • Haemonetics
  • MasterControl
  • TraceLink
  • TrakCel
  • Stafa Cellular Therapy
  • McKesson
  • BioLife Solutions
  • Patheon
  • SF Express

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Supply Chain and Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Supply Chain and Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Supply Chain and Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Supply Chain and Logistics Industry Restraints
3 Cell and Gene Therapy Supply Chain and Logistics Market by Company
  1. 3.1 Global Cell and Gene Therapy Supply Chain and Logistics Company Revenue Ranking in 2025
  2. 3.2 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Company (2021-2026)
  3. 3.3 Global Cell and Gene Therapy Supply Chain and Logistics Company Ranking (2024-2026)
  4. 3.4 Global Cell and Gene Therapy Supply Chain and Logistics Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell and Gene Therapy Supply Chain and Logistics Company Product Type and Application
  6. 3.6 Global Cell and Gene Therapy Supply Chain and Logistics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell and Gene Therapy Supply Chain and Logistics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell and Gene Therapy Supply Chain and Logistics Market by Type
  1. 4.1 Cell and Gene Therapy Supply Chain and Logistics Type Introduction
  2. 4.1.1 Ordering and Scheduling Services
  3. 4.1.2 Sample Collection Services
  4. 4.1.3 Logistics Services
  5. 4.1.4 Post Treatment Follow-Up Services
  6. 4.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type
  7. 4.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type (2021-2032)
5 Cell and Gene Therapy Supply Chain and Logistics Market by Application
  1. 5.1 Cell and Gene Therapy Supply Chain and Logistics Application Introduction
  2. 5.1.1 Biobank
  3. 5.1.2 Cell Therapy Lab
  4. 5.1.3 Hospital
  5. 5.1.4 Research Institute
  6. 5.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application
  7. 5.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application (2021-2032)
6 Cell and Gene Therapy Supply Chain and Logistics Regional Value Analysis
  1. 6.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032)
  7. 6.3.2 North America Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032)
  10. 6.4.2 Europe Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032)
  16. 6.6.2 South America Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Country, 2025 VS 2032
7 Cell and Gene Therapy Supply Chain and Logistics Country-level Value Analysis
  1. 7.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell and Gene Therapy Supply Chain and Logistics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell and Gene Therapy Supply Chain and Logistics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Be The Match BioTherapies
  2. 8.1.1 Be The Match BioTherapies Company Information
  3. 8.1.2 Be The Match BioTherapies Business Overview
  4. 8.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  6. 8.1.5 Be The Match BioTherapies Recent Developments
  7. 8.2 Biocair
  8. 8.2.1 Biocair Company Information
  9. 8.2.2 Biocair Business Overview
  10. 8.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  12. 8.2.5 Biocair Recent Developments
  13. 8.3 Marken
  14. 8.3.1 Marken Company Information
  15. 8.3.2 Marken Business Overview
  16. 8.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  18. 8.3.5 Marken Recent Developments
  19. 8.4 World Courier
  20. 8.4.1 World Courier Company Information
  21. 8.4.2 World Courier Business Overview
  22. 8.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  24. 8.4.5 World Courier Recent Developments
  25. 8.5 MAK-SYSTEM
  26. 8.5.1 MAK-SYSTEM Company Information
  27. 8.5.2 MAK-SYSTEM Business Overview
  28. 8.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  30. 8.5.5 MAK-SYSTEM Recent Developments
  31. 8.6 Cryoport
  32. 8.6.1 Cryoport Company Information
  33. 8.6.2 Cryoport Business Overview
  34. 8.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  36. 8.6.5 Cryoport Recent Developments
  37. 8.7 Brooks Life Sciences
  38. 8.7.1 Brooks Life Sciences Company Information
  39. 8.7.2 Brooks Life Sciences Business Overview
  40. 8.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  42. 8.7.5 Brooks Life Sciences Recent Developments
  43. 8.8 Hypertrust Patient Data Care
  44. 8.8.1 Hypertrust Patient Data Care Company Information
  45. 8.8.2 Hypertrust Patient Data Care Business Overview
  46. 8.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  48. 8.8.5 Hypertrust Patient Data Care Recent Developments
  49. 8.9 Haemonetics
  50. 8.9.1 Haemonetics Company Information
  51. 8.9.2 Haemonetics Business Overview
  52. 8.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  54. 8.9.5 Haemonetics Recent Developments
  55. 8.10 MasterControl
  56. 8.10.1 MasterControl Company Information
  57. 8.10.2 MasterControl Business Overview
  58. 8.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  60. 8.10.5 MasterControl Recent Developments
  61. 8.11 TraceLink
  62. 8.11.1 TraceLink Company Information
  63. 8.11.2 TraceLink Business Overview
  64. 8.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  66. 8.11.5 TraceLink Recent Developments
  67. 8.12 TrakCel
  68. 8.12.1 TrakCel Company Information
  69. 8.12.2 TrakCel Business Overview
  70. 8.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  72. 8.12.5 TrakCel Recent Developments
  73. 8.13 Stafa Cellular Therapy
  74. 8.13.1 Stafa Cellular Therapy Company Information
  75. 8.13.2 Stafa Cellular Therapy Business Overview
  76. 8.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  78. 8.13.5 Stafa Cellular Therapy Recent Developments
  79. 8.14 McKesson
  80. 8.14.1 McKesson Company Information
  81. 8.14.2 McKesson Business Overview
  82. 8.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  84. 8.14.5 McKesson Recent Developments
  85. 8.15 BioLife Solutions
  86. 8.15.1 BioLife Solutions Company Information
  87. 8.15.2 BioLife Solutions Business Overview
  88. 8.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  90. 8.15.5 BioLife Solutions Recent Developments
  91. 8.16 Patheon
  92. 8.16.1 Patheon Company Information
  93. 8.16.2 Patheon Business Overview
  94. 8.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  96. 8.16.5 Patheon Recent Developments
  97. 8.17 SF Express
  98. 8.17.1 SF Express Company Information
  99. 8.17.2 SF Express Business Overview
  100. 8.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  102. 8.17.5 SF Express Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst